# SUGAMMADEX SODIUM
> **ANDA214337** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-06-09
## Drug
- **FDA Application Number:** ANDA214337
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUGAMMADEX SODIUM
- **Generic name:** Sugammadex Sodium
- **Active ingredients:** SUGAMMADEX SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **First approval:** 2023-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214337)
---
*AI Analytics · CC0 1.0*